ALERT

In Observance of U.S. holiday, Memorial Day, Agilent CrossLab, iLab Operations Software will be closed during U.S. hours and have support during EU and APAC hours on Monday May 29th, 2017. We will resume U.S. support hours on Tuesday May 30th, 2017. For urgent matters, please add "Urgent" to the ticket subject and we will prioritize those requests first.

Thank you,

Johns Hopkins Drug Discovery Group

Overview of Services

Located in the new Biotechnology Park, Johns Hopkins Drug Discovery Program was created in 2010 with the mission of identifying novel drug targets arising from JHU faculty’s research and translating them into new drug therapies for a wide range of human disorders.   

The multidisciplinary team of scientists has provided the Johns Hopkins community with core expertise in drug discovery research including medicinal chemistry, screening assay development, drug metabolism and pharmacokinetics, animal pharmacology/toxicology, and the knowledge necessary to bring novel drugs to the clinic. 

Leadership

Barbara S. Slusher, PhD, MAS
Director, Johns Hopkins Drug Discovery Program
Professor, Neurology, Medicine, Psychiatry, Neuroscience and Oncology
Tel: 410-614-0662
Email: bslusher@jhmi.edu

Takashi Tsukamoto, PhD
Director, Medicinal Chemistry
Associate Professor, Neurology
Tel: 410-614-0982
Email: ttsukamoto@jhmi.edu

Rana Rais, PhD
Director, Drug Metabolism & Pharmacokinetics
Assistant Professor, Neurology 
Tel: 410-614-1906
Email: rrais2@jhmi.edu

Camilo Rojas, PhD
Director, Biochemistry and Assay Development
Assistant Professor, Molecular and Comparative Pathobiology
Tel: 410-614-0870
Email: crojas2@jhmi.edu

Location and hours of operation

Hours of Operation: 

Monday - Friday 8:30am - 5:00pm

Location:

The John G. Rangos, Sr. Building

855 N. Wolfe Street, Suite 270

Baltimore, Maryland 21205

Tel: 410-614-1065 (Angie Rubin, Administrative Manager)

Fax: 410-614-0659

Email: arubin12@jhmi.edu

   
   

Links and Resources

  1. Johns Hopkins Drug Discovery Group Website

Map